Sean P. Duffy Sells $249K of Omada Health Inc (OMDA) — SEC Form 4, Nov 06, 2026

Open-Market Net Sale · SEC Form 4
−$248,731
10b5-1 Plan (Partial)
Reporting Owner
TXN 2026-11-04 · FILED 2026-11-06
Equity Position 1.25M sh 1,247,197 → 1,247,197
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-11-06
Report Date
2026-11-06
Accession No.
0001610717-26-000446
Accepted At
2026-11-06 21:38 UTC
Reporting Owner
Name Relationship
Sean P. Duffy CIK 0002069522
Director CEO
Sean P. Duffy at Omada Health Inc Full insider history
Bought (12 mo) —
Sold (12 mo) $7,851,526
More from this insider at Omada Health Inc
2026-10-05 Sell -$356,915 View
2026-09-14 Sell -$327,197 View
2026-09-09 - — View
2026-09-03 Sell -$509,465 View
2026-08-11 Sell -$509,580 View
All filings by this insider at Omada Health Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1 2026-11-04 M - Exercise 10b5-1 12,944 A $5.82 +$75,334 395,538 Direct
Common StockF1F2 2026-11-04 S - Sale 10b5-1 12,944 D $19.22 -$248,731 382,594 Direct
Derivative Securities Transactions
Title Strike Date Type Shares Price Expiration Underlying Ownership
Stock Option (Right to Buy)F4 $5.82 2026-11-04 M - Exercise 12,944 D $0.00 2029-08-21 12,944 Common Stock Direct
Non-Derivative Holdings
Title Shares Held Ownership
Common StockF3 851,659 Indirect See footnote
Footnotes (4)
F1
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the Reporting Person. Show more
F2
This transaction was executed in multiple trades at prices ranging from $19.11 to $19.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Show more
F3
Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein. Show more
F4
100% of the shares subject to the option are fully vested and exercisable. Show more
5%+ Holders · 13D/G 4 filers
Other insiders at Omada Health Inc
All Omada Health Inc insider activity
GET /v1/forms/4/0001610717-26-000446 API docs
View Original SEC Filing